Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Maitreya MedicareNSE:MAITREYA 13 Earnings per Share (Diluted) is ₹-3.64 as of Mar. 2026. GuruFocus rates NSE:MAITREYA with a GF Score™ of 13/100. The stock has 7 warning signs investors should review. Among 503 Healthcare Providers & Services companies, Maitreya Medicare ranks worse than 198806.96% on this metric.
Maitreya Medicare's EPS (Basic) for the
six
months ended in Mar. 2026 was ₹-3.59.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-3.64.
During the past 3 years, Maitreya Medicare's highest 3-Year average EPS without NRI Growth Rate was -24.50% per year. The lowest was -24.50% per year. And the median was -24.50% per year.
Maitreya Medicare (NSE:MAITREYA) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Maitreya Medicare Earnings per Share (Diluted) Related Terms
Maitreya Medicare Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Maitreya Medicare's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maitreya Medicare Earnings per Share (Diluted) Chart
Maitreya Medicare Annual Data
Trend
Mar24
Mar25
Mar26
Earnings per Share (Diluted)
4.15
2.68
-3.64
Maitreya Medicare Semi-Annual Data
Sep24
Mar25
Sep25
Mar26
Earnings per Share (Diluted)
2.59
0.22
-0.05
-3.59
NSE:MAITREYA vs HCA, DVA, THC: Earnings per Share (Diluted) Comparison
For the Medical Care Facilities subindustry, Maitreya Medicare's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maitreya Medicare PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Maitreya Medicare's PE Ratio distribution charts can be found below:
* The bar in red indicates where Maitreya Medicare's PE Ratio falls into.
Maitreya Medicare Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Maitreya Medicare's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2026 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-3.64
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of ₹-3.64 mean?
Maitreya Medicare (NSE:MAITREYA) has a Earnings per Share (Diluted) of ₹-3.64 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Maitreya Medicare and its competitors. According to the industry distribution chart, Maitreya Medicare ranks #999999 out of 503 companies in the Healthcare Providers & Services industry.
Is Maitreya Medicare's Earnings per Share (Diluted) too high?
Maitreya Medicare's current Earnings per Share (Diluted) is ₹-3.64. Based on the distribution chart, Maitreya Medicare ranks #999999 out of 503 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Maitreya Medicare has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Earnings per Share (Diluted) compare to HCA and DVA?
According to the Healthcare Providers & Services industry distribution chart, Maitreya Medicare ranks #999999 out of 503 companies for Earnings per Share (Diluted). This places Maitreya Medicare in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.00, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Maitreya Medicare and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maitreya Medicare's current Earnings per Share (Diluted) is ₹-3.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Maitreya Medicare (NSE:MAITREYA) has a current Earnings per Share (Diluted) of ₹-3.64. The current Earnings per Share (Diluted) is ₹-3.64. Maitreya Medicare's overall GF Score™ is 13/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Earnings per Share (Diluted) is ₹-3.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
13GF Score
Get the complete analysis for NSE:MAITREYA
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAITREYA has been successfully added to your 
